Karen Chung

Karen Chung currently serves as the VP of Health Economics & Market Access at Viking Therapeutics, Inc., a position held since September 2024. Previously, Karen was the Head of Health Economics & Outcomes Research at GRAIL from May 2019 to August 2024. Prior experience includes holding senior roles at Juno Therapeutics, Inc., Jazz Pharmaceuticals, Gilead Sciences, and Amgen, with a focus on health economics and outcomes research. Earlier career positions were at Baxter Healthcare and Bayer Pharmaceuticals, contributing to clinical development and health economics. Educational qualifications include a Doctor of Pharmacy from the University of Southern California and an MS in Pharmacy Administration from the University of Arizona.